HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

3- ((4- (6- bromo- 2- (4- (4- methylpiperazin- 1- yl)phenyl)- 3H- imidazo(4,5- b)pyridin- 7- yl)piperazin- 1- yl)methyl)- 5- methylisoxazole

highly selective inhibitor of aurora kinases A and B
Also Known As:
CCT 137690; CCT-137690; CCT137690
Networked: 6 relevant articles (1 outcomes, 3 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Faisal, Amir: 2 articles (01/2019 - 11/2011)
2. Asik, Aycan: 1 article (01/2021)
3. Avci, Cigir B: 1 article (01/2021)
4. Gasimli, Roya: 1 article (01/2021)
5. Gunduz, Cumhur: 1 article (01/2021)
6. Kayabasi, Cagla: 1 article (01/2021)
7. Kipcak, Sezgi: 1 article (01/2021)
8. Sogutlu, Fatma: 1 article (01/2021)
9. Susluer, Sunde Y: 1 article (01/2021)
10. Yelken, Besra O: 1 article (01/2021)

Related Diseases

1. Mouth Neoplasms (Oral Cancer)
2. Neoplasms (Cancer)
3. Colorectal Neoplasms (Colorectal Cancer)
4. Melanoma (Melanoma, Malignant)
5. Breast Neoplasms (Breast Cancer)

Related Drugs and Biologics

1. Nanocapsules
2. Drug Combinations
3. Aurora Kinases
4. Estrogen Receptors
5. Aurora Kinase A
6. Long Noncoding RNA
7. Phosphatidylinositol 3-Kinases (PI 3 Kinase)
8. Polyethylene Glycols (Polyethylene Glycol)
9. Gefitinib (Iressa)
10. N-Myc Proto-Oncogene Protein

Related Therapies and Procedures

1. Oral Administration